An experimental cell-based model for studying the cell biology and molecular pharmacology of 5-lipoxygenase-activating protein in leukotriene biosynthesis

Biochim Biophys Acta. 2014 Sep;1840(9):2961-9. doi: 10.1016/j.bbagen.2014.05.016. Epub 2014 Jun 4.

Abstract

Background: Subcellular distribution of 5-lipoxygenase (5-LO) to the perinuclear region and interaction with the 5-LO-activating protein (FLAP) are assumed as key steps in leukotriene biosynthesis and are prone to FLAP antagonists.

Methods: FLAP and/or 5-LO were stably expressed in HEK293 cells, 5-LO products were analyzed by HPLC, and 5-LO and FLAP subcellular localization was visualized by immunofluorescence microscopy.

Results: 5-LO and FLAP were stably expressed in HEK293 cells, and upon Ca(2+)-ionophore A23187 stimulation exogenous AA was efficiently transformed into the 5-LO products 5-hydro(pero)xyeicosatetraenoic acid (5-H(p)ETE) and the trans-isomers of LTB4. A23187 stimulation caused 5-LO accumulation at the nuclear membrane only when FLAP was co-expressed. Unexpectedly, A23187 stimulation of HEK cells expressing 5-LO and FLAP without exogenous AA failed in 5-LO product synthesis. HEK cells liberated AA in response to A23187, and transfected HEK cells expressing 12-LO generated 12-HETE after A23187 challenge from endogenous AA. FLAP co-expression increased 5-LO product formation in A23187-stimulated cells at low AA concentrations. Only in cells expressing FLAP and 5-LO, the FLAP antagonist MK886 blocked FLAP-mediated increase in 5-LO product formation, and prevented 5-LO nuclear membrane translocation and co-localization with FLAP.

Conclusion: The cellular biosynthesis of 5-LO products from endogenously derived substrate requires not only functional 5-LO/FLAP co-localization but also additional prerequisites which are dispensable when exogenous AA is supplied; identification of these determinants is challenging.

General significance: We present a cell model to study the role of FLAP as 5-LO interacting protein in LT biosynthesis in intact cells and for characterization of putative FLAP antagonists.

Keywords: 12-Lipoxygenase; 5-Lipoxygenase; 5-Lipoxygenase-activating protein; Arachidonic acid; HEK293 cells; MK886.

MeSH terms

  • 5-Lipoxygenase-Activating Proteins / genetics
  • 5-Lipoxygenase-Activating Proteins / metabolism*
  • Arachidonate 5-Lipoxygenase / genetics
  • Arachidonate 5-Lipoxygenase / metabolism*
  • Calcimycin / pharmacology
  • Calcium Ionophores / pharmacology
  • Cell Nucleus / enzymology*
  • Cell Nucleus / genetics
  • HEK293 Cells
  • Humans
  • Indoles / pharmacology*
  • Leukotrienes / biosynthesis*
  • Leukotrienes / genetics
  • Lipoxygenase Inhibitors / pharmacology*

Substances

  • 5-Lipoxygenase-Activating Proteins
  • ALOX5AP protein, human
  • Calcium Ionophores
  • Indoles
  • Leukotrienes
  • Lipoxygenase Inhibitors
  • MK-886
  • Calcimycin
  • Arachidonate 5-Lipoxygenase